---
title: "Aeon Biopharma Gets NYSE American Noncompliance Notice"
date: "2025-02-08 06:05:05"
summary: "Aeon Biopharma said Friday it received a notice from NYSE American stating it is not in compliance with the stockholders' equity requirement, which requires at least $2 million in equity. The company reported a stockholders' deficit of $32.1 million as of Sept. 30 and has incurred losses from continued operations..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Aeon Biopharma said Friday it received a notice from NYSE American stating it is not in compliance with the stockholders' equity requirement, which requires at least $2 million in equity.

The company reported a stockholders' deficit of $32.1 million as of Sept. 30 and has incurred losses from continued operations in two of its most recent fiscal years.

Aeon said it has until March 5 to submit a plan to regain compliance and intends to do so

Shares of Aeon Biopharma were down more than 7% in after-hours trading.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250207:A3313076:0/)
